"Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection"
http://jama.jamanetwork.com/article.aspx?articleid=1889138
"Conclusions and Relevance In this open-label, nonrandomized, uncontrolled study, patients with HIV who were coinfected with HCV genotype 1, 2, or 3 who received the oral, interferon-free combination of sofosbuvir and ribavirin for 12 or 24 weeks had high rates of SVR12. Further studies of this oral regimen in diverse populations of coinfected patients are warranted."
No comments:
Post a Comment